Pharmacokinetics of once-daily doravirine over 72 h following drug cessation

J Antimicrob Chemother. 2020 Jun 1;75(6):1658-1660. doi: 10.1093/jac/dkaa038.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Pharmaceutical Preparations*
  • Pyridones*
  • Reverse Transcriptase Inhibitors
  • Triazoles

Substances

  • Pharmaceutical Preparations
  • Pyridones
  • Reverse Transcriptase Inhibitors
  • Triazoles
  • doravirine